QUALITY AND SAFETY. All materials used for the manufacture or construction of any supplies, materials or equipment covered by this bid shall be new. The items bid must be new, the latest model, of the best quality, and highest grade workmanship that meet or exceed federal safety standards. Products requiring certification should require certification of options in cases where non-certified options could result in the decertification of the original product or warranty. In all cases where options are not certified, the Vendor must disclose to the end user that the non-certified options are not required to be certified. All options must meet or exceed federal safety standards.
QUALITY AND SAFETY. All materials used for the manufacture or construction of any supplies, materials or equipment covered by this bid shall be new. The items bid must be new, the latest model, of the best quality, and highest-grade workmanship that meet or exceed federal safety standards. Products requiring certification should require certification of options in cases where non-certified options could result in the decertification of the original product or warranty. In all cases where options are not certified, the vendor must disclose to the end user that the non-certified options are not required to be certified. All options must meet or exceed federal safety standards. Bidders shall offer only those brands qualified and listed in Cooperative Approved Tire List (CATL), latest edition in effect at the time of this solicitation, published by the Associated Consultants of Technical Services, Inc., the contract manager for the Federal Government’s program for testing new tire performance. In lieu of being listed in the publications, a Bidder may provide a Qualification Certification Form signed by the CATL Program Administrator. Tires bid must meet the following standards: • ASTM Standard F1922, Test Method-for Tires, Pneumatic, Vehicular Highway. • ASTM Standard F1923, Test Method-for Tires, Pneumatic, Vehicular Low Speed, Off Highway. • ASTM Standard for Rubber Tires.
QUALITY AND SAFETY. The Bidder shall provide the names of at least 3 reputed agencies with experience of conducting quality and safety checks in similar works. IWAI shall approve one of the three agencies to certify design and technical specifications and conduct testing and commissioning for final certification.
QUALITY AND SAFETY. (i) Notwithstanding anything in this Agreement to the contrary, all Materials (including Licensed Product provided pursuant to Section 4.3(a)) provided to OST by or on behalf of Advaxis are provided on an “AS-IS” basis and subject to the disclaimer of Section 9.4 of the Agreement. OST shall be responsible for (i) the Materials meeting any and all clinical and commercial supply, shelf-life, efficacy, design, safety, and quality requirements; and (ii) the testing of Materials and Licensed Products to assure that they meet applicable specifications and quality standards. Any additional supply of Materials provided to OST by or on behalf of Advaxis shall be provided at OST’s sole cost and expense.
(ii) Advaxis shall have the right to perform and conduct quality and safety audits of OST, or participate with OST in its quality and/or facilities audit of its Third Parties utilized for sequencing, manufacturing, testing, disposition, storage, or transportation of Materials once per twelve (12) month period, or at any time in the event of a material quality or safety issue. From time to time, Advaxis shall have the right to conduct safety-related site visits and audits, or designate an independent monitor, for all Clinical Trials, in each case in accordance with any applicable Pharmacovigilance Agreement agreed upon by the parties in accordance with Section 4.2(d).
QUALITY AND SAFETY. 7.3.1. South Yorkshire and Bassetlaw has a well-established quality and safety approach at, organisation, place and system level. And much of what is described in this MoU is about improving quality and safety, either through our organisations choosing to work together on common challenges and those key priorities which are most in need of a different way of working and collaboration or most likely to deliver improvements through our joint efforts.
7.3.2. We commit to reviewing our approaches in light of developing as an ACS in 2017/18 to ensure our quality and safety oversight and assurance best support how we are coming together in Place, as emerging ACPs and across SYB as an overall ACS. We will also align NHS England and NHS Improvement resources to support an integrated function to enable us to streamline our approach and be more effective.
7.3.3. There is growing evidence that that the improvements we are aiming to achieve within our plan will give measurable improvements in quality ahead of any financial efficiency improvements. We would therefore want to develop clear quality metrics for SYB to enable us to track these quality improvements.
QUALITY AND SAFETY. 8.1 Inspections and Audits.
(a) Prior to obtaining Regulatory Approval for the Product in the Territory, Lilly shall notify United Therapeutics within one (1) Business Day after Lilly learns that an inspection of the Manufacturing Facility with respect to the Product by FDA has been scheduled by FDA or, if such an inspection occurs without prior notice to Lilly, within one (1) Business Day after such inspection is conducted by FDA. Lilly shall provide United Therapeutics a summary of the findings contained in a Form 483 resulting from such inspection specific to the Product and a summary of Lilly’s response to such Form 483.
(b) After obtaining Regulatory Approval for the Product in the Territory, if a Regulatory Authority conducts an inspection of the Manufacturing Facility with respect to the Product and, as a result of such inspection, Lilly receives a FDA Form 483 that would reasonably be expected to affect the supply of the Product, Lilly shall promptly provide United Therapeutics a summary of the findings contained in such FDA Form 483 and a summary of Lilly’s response to such Form 483.
(c) Upon no less than sixty (60) days’ written notice to Lilly and no more than one (1) time each Calendar Year, Lilly shall permit United Therapeutics or its appointed representatives (such representatives to be reasonably acceptable to Lilly) to audit Lilly’s processes, procedures and records at or in respect of the Manufacturing Facility and Lilly’s distribution systems during regular business hours for the purpose of making quality control inspections to ensure compliance with Applicable Law of the Manufacturing Facility and distribution systems used in the manufacturing, receiving, sampling, analyzing, storing, handling, packaging and shipping of the Product, including, but not limited to, in the receipt, storage and issuance of raw materials, labeling and packaging components, and ingredients thereof; provided that United Therapeutics shall have no access to any areas of the Manufacturing Facility where such access would be likely to result in the disclosure of any of Lilly’s trade secrets. Notwithstanding the foregoing sentence, in the event of a material breach of this Agreement, a rejection of the Product by United Therapeutics pursuant to Section 8.6 because of a failure to meet the Specifications, or a material regulatory issue or series of issues at any time, United Therapeutics shall have an additional right to conduct an audit under the provisions of thi...
QUALITY AND SAFETY. Company shall use its best efforts to ensure that the Product designed, manufactured, distributed, and sold by Company will be of high quality and free of defects in materials and workmanship.
QUALITY AND SAFETY. Demonstrate a commitment to the delivery of safe and high quality services. • Demonstrate a focus on partnering with consumers in the planning, delivery and evaluation of services and care, by actively seeking feedback and engaging consumers in their care planning as appropriate to employee role. • Ensure all activities are in accordance with the following standards as applicable to the employee’s work area: o National Safety and Quality Health Service Standards (organisation wide); o Aged Care Quality Standards (Lewington House and Home & Community Care); o Royal Australian College of General Practitioners Standards (Medical Centre). • Actively participate in the Omeo District Health quality improvement program and accreditation processes against the above standards, as appropriate to employee role. • Be confidently able to complete an incident report and submit a quality activity in Riskman. • Be able to identify risks and follow the Omeo District Health Risk Management Policy and procedure. • Have, or participate in, processes to monitor and evaluate the performance of the services provided by the work area. • Participates in annual performance review and development program. • Maintain knowledge required for the performance of the position. • Attend ODH Mandatory Education Training annually.
QUALITY AND SAFETY. Framework The Service Provider will demonstrate continuous quality improvement and safety activity to the satisfaction of the Crown in accordance with the Quality and Safety Framework for Tasmania’s DHHS Funded Community Sector.
QUALITY AND SAFETY. Initiates and participates in the development of formal Nursing/Midwifery quality improvement and risk management projects and programs, ensuring an evidenced-based outcome-focused culture of improving performance. • Promotes and facilitates nursing/midwifery compliance with National Safety & Quality Health Service Standards. • Promotes and facilitates adherence to, and monitoring of Nurse/Midwife Sensitive Indicators for areas of responsibility. • Implements and maintains performance management systems which support ongoing development of staff. • In partnership with other health professionals leads the establishment and maintenance of a culture of patient safety within their area of specialty and contributes to the Service wide initiatives.
